Also, increases in IL-6 with an anti-inflammatory characteristic have been the target of encouraging studies involving a possible therapeutic effect of IL-6 in chronic diseases that establish a chronic environment of low-grade inflammation, such as arthritis rheumatoid (Carey et al., 2006), sarcopenia (Beyer et al., 2012) and even cancer (Daou, 2020). The gene discussed is IL6; the disease is arthritic joint disease.